Table 5.
Recommendations for the Study Design of New Trials
| Recommendations for new studies | |
|---|---|
| Quality of the study | 1. Controlled design (comparison with standard treatment or placebo) 2. Randomized 3. Minimal follow-up duration of 12 months 4. Following CONSORTa statement for reporting 5. Statistically testing for differences between groups |
| Standardization of the procedure | 1. Standardized harvesting, processing and injection technique 2. Standardized injection volume and volume-to-volume ratio of supplement-to-fat graft 3. No concomitant procedures (eg, facelift) that can influence volume or satisfaction outcomes 4. Single injections, no repeated procedures |
| Measurement of volume retention | 1. Clear definition of how retention is measured, based on injected volume or based on first volume measurement after surgery 2. Using valid imaging modalities (without ionizing radiation) 3. Using a reliable method of volume measurement, by either reporting reliability or using a validated method of volume measurement |
| Measurement of patient satisfaction | 1. Using a validated PROMb 2. Measuring change of PROM, including a preoperative (baseline) measurement 3. Statistically testing for difference of PROM between intervention and control group 4. Observer/surgeon should not be present when PROM is recorded, to exclude interviewer/social desirability bias |
aConsolidated Standards of Reporting Trials.
bPatient-reported outcome measures.